The gap between the 21.23 trailing P/E and the 13.23 forward P/E suggests the market is pricing in recovery from the weak 1Q26 and 2Q26 earnings rather than the trailing run-rate. A P/B near 1.01 against a ROE that has mostly ranged between 1.0% and 2.0% implies the market is paying for franchise value and expected normalization of returns rather than current profitability. Investors should monitor whether ROTCE recovers toward peer levels, since the current multiple appears to embed a Florida growth premium that depends on that recovery.

With an equity-to-assets ratio near 0.14 and a net interest margin of only 0.9%, the DuPont structure shows that low asset yield is being amplified by leverage, but the leverage is not enough to lift returns to peer levels. The fee-income contribution has been erratic, turning negative in 1Q26 and 4Q25, which removes the diversification that would otherwise support ROE. The profitability picture appears structurally weaker than the valuation implies, warranting further investigation into whether acquisition accounting is flattering the margin base.

The efficiency improvement in 3Q26 appears to reflect revenue scaling faster than expenses, but a flat NIM across ten quarters suggests that operating leverage is coming from balance sheet growth and acquired scale rather than from pricing power. The 62.0% level remains elevated compared with the 56.2% to 65% range seen in earlier quarters, so the gain may not be durable. Investors should monitor whether purchase accounting accretion is inflating the NIM, since stripping that out may show a lower core margin.

Stable equity-to-assets through rapid acquisition-driven growth suggests capital has kept pace with balance sheet expansion, which is a positive for regulatory headroom. However, the supplied data does not include CET1, Tier 1, or total risk-based capital ratios, so the regulatory capacity for further capital return cannot be assessed with confidence. Investors should treat this as a provisional read until risk-weighted capital ratios are reviewed.

The provision pattern may reflect CECL-driven macroeconomic reserve adjustments rather than realized deterioration, which makes the 4Q25 spike difficult to interpret without charge-off data. The supplied set does not include NPL or coverage ratios, so reserve adequacy cannot be confirmed. Given Florida real estate concentration, the sharp reserve swing warrants further investigation into the underlying loan book composition.

SBCF screens cheap against peers on P/B yet also trails them sharply on ROE, which suggests the discount reflects structural profitability weakness rather than mispricing alone. The gap appears more cyclical than structural if forward earnings normalize, but the supplied data does not establish that normalization. Investors should compare the valuation gap against the timing of any ROE recovery before assuming the discount is unwarranted.